OA

Omri Amirav Drory

General Partner at NFX

Menlo Park, California

Overview 

Omri Amirav Drory is currently a General Partner at NFX, with a background in genomics, bioinformatics, and biotechnology. He has founded Renewal Bio and serves on the boards of various biotech companies, showcasing his expertise in the field and his ability to drive successful ventures. Drory's career highlights include founding Renewal Bio and serving on the boards of several biotech companies, demonstrating his leadership and impact in the industry through his strategic involvement in various ventures. His current role as a General Partner at NFX further solidifies his position as a key figure in the biotech and genomics sector.

Work Experience 

  • Board Member

    2024 - Current

  • Board Member

    2024

TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.

Raised $6,500,000.00 from Alexandria Venture Investments, 2048 Ventures, NFX and GC&H Investments.

  • Board Member

    2023

ZipBio develops next-gen gene therapies using machine learning, protein engineering, and molecular materials.

Raised $4,000,000.00 from MoreVC and NFX.

  • Board Member

    2022

Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.

Raised $14,200,000.00 from NFX and Global Health Investment Corporation.

  • Founder & CEO

    2022

    Renewal - Renewing human health

  • Board Member

    2021

Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.

Raised $27,781,502.00 from NFX, FundersClub, BoxOne Ventures, Two Bear Capital, Y Combinator Continuity Fund, Rolling Bay Ventures and WRF Capital.

  • Board Member

    2021

Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.

Raised $29,500,000.00 from Technion - Israel Institute of Technology, NFX, LionBird, Andreessen Horowitz, Base4 Capital and NFX.

  • Board Member

    2021

La Jolla Labs is a therapeutics company that delivers high-throughput screening technology for drug discovery.

  • Board Member

    2021

  • Board Member

    2021

Pepper Bio is a trans-omics company that helps researchers and drug developers discover new drugs.

Raised $6,500,000.00 from big_bets, Tensility Venture Partners, NFX, Mana Ventures, VSC Ventures, Merck Digital Sciences Studio, Silverton Partners and Reinforced Ventures.

Articles About Omri

Relevant Websites